nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A4—prostate cancer	0.147	1	CbGaD
Dextropropoxyphene—CYP2C8—Nilutamide—prostate cancer	0.046	0.0804	CbGbCtD
Dextropropoxyphene—CYP2C8—Abiraterone—prostate cancer	0.0381	0.0666	CbGbCtD
Dextropropoxyphene—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0355	0.0621	CbGbCtD
Dextropropoxyphene—CYP2C9—Bicalutamide—prostate cancer	0.0321	0.0561	CbGbCtD
Dextropropoxyphene—CYP2C9—Nilutamide—prostate cancer	0.0321	0.0561	CbGbCtD
Dextropropoxyphene—CYP2D6—Bicalutamide—prostate cancer	0.0293	0.0513	CbGbCtD
Dextropropoxyphene—CYP2C8—Cabazitaxel—prostate cancer	0.0282	0.0493	CbGbCtD
Dextropropoxyphene—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0246	0.0429	CbGbCtD
Dextropropoxyphene—CYP2D6—Abiraterone—prostate cancer	0.0243	0.0425	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0219	0.0384	CbGbCtD
Dextropropoxyphene—CYP3A7—Estradiol—prostate cancer	0.0219	0.0384	CbGbCtD
Dextropropoxyphene—CYP2C9—Estrone—prostate cancer	0.0192	0.0336	CbGbCtD
Dextropropoxyphene—CYP3A4—Bicalutamide—prostate cancer	0.0187	0.0326	CbGbCtD
Dextropropoxyphene—CYP3A4—Estramustine—prostate cancer	0.0173	0.0303	CbGbCtD
Dextropropoxyphene—CYP2C8—Estradiol—prostate cancer	0.0158	0.0277	CbGbCtD
Dextropropoxyphene—CYP3A4—Flutamide—prostate cancer	0.0155	0.027	CbGbCtD
Dextropropoxyphene—CYP3A4—Abiraterone—prostate cancer	0.0155	0.027	CbGbCtD
Dextropropoxyphene—CYP2C9—Capecitabine—prostate cancer	0.0146	0.0255	CbGbCtD
Dextropropoxyphene—CYP3A7—Docetaxel—prostate cancer	0.0131	0.0229	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.0131	0.0229	CbGbCtD
Dextropropoxyphene—CYP3A4—Cabazitaxel—prostate cancer	0.0114	0.02	CbGbCtD
Dextropropoxyphene—CYP3A4—Estrone—prostate cancer	0.0112	0.0195	CbGbCtD
Dextropropoxyphene—CYP2C9—Estradiol—prostate cancer	0.011	0.0193	CbGbCtD
Dextropropoxyphene—CYP2C8—Etoposide—prostate cancer	0.0103	0.0181	CbGbCtD
Dextropropoxyphene—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00996	0.0174	CbGbCtD
Dextropropoxyphene—CYP3A4—Conjugated Estrogens—prostate cancer	0.00731	0.0128	CbGbCtD
Dextropropoxyphene—CYP3A4—Mitoxantrone—prostate cancer	0.00665	0.0116	CbGbCtD
Dextropropoxyphene—CYP3A4—Estradiol—prostate cancer	0.00642	0.0112	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisone—prostate cancer	0.00552	0.00965	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—prostate cancer	0.0045	0.00786	CbGbCtD
Dextropropoxyphene—CYP3A4—Etoposide—prostate cancer	0.00419	0.00732	CbGbCtD
Dextropropoxyphene—CYP3A4—Docetaxel—prostate cancer	0.00383	0.0067	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—prostate cancer	0.00286	0.005	CbGbCtD
Dextropropoxyphene—Dimetacrine—ACHE—prostate cancer	0.000436	0.0877	CrCbGaD
Dextropropoxyphene—Tamoxifen—SULT1A1—prostate cancer	0.000411	0.0826	CrCbGaD
Dextropropoxyphene—Quinapril—ACE—prostate cancer	0.000231	0.0466	CrCbGaD
Dextropropoxyphene—Disopyramide—SLC22A1—prostate cancer	0.000216	0.0434	CrCbGaD
Dextropropoxyphene—Toremifene—ESR1—prostate cancer	0.000178	0.0359	CrCbGaD
Dextropropoxyphene—Phenoxybenzamine—SLC22A3—prostate cancer	0.000178	0.0357	CrCbGaD
Dextropropoxyphene—Hypotension—Mitoxantrone—prostate cancer	0.000151	0.000934	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Estradiol—prostate cancer	0.00015	0.000926	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Goserelin—prostate cancer	0.00015	0.000926	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Prednisone—prostate cancer	0.000149	0.000921	CcSEcCtD
Dextropropoxyphene—Constipation—Estradiol—prostate cancer	0.000149	0.000917	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000149	0.000917	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Prednisone—prostate cancer	0.000149	0.000916	CcSEcCtD
Dextropropoxyphene—Eye disorder—Docetaxel—prostate cancer	0.000147	0.000909	CcSEcCtD
Dextropropoxyphene—Visual impairment—Capecitabine—prostate cancer	0.000147	0.000907	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Docetaxel—prostate cancer	0.000146	0.000903	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Epirubicin—prostate cancer	0.000146	0.000902	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Etoposide—prostate cancer	0.000145	0.000895	CcSEcCtD
Dextropropoxyphene—Dizziness—Goserelin—prostate cancer	0.000145	0.000895	CcSEcCtD
Dextropropoxyphene—Ataxia—Epirubicin—prostate cancer	0.000145	0.000892	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Mitoxantrone—prostate cancer	0.000144	0.000891	CcSEcCtD
Dextropropoxyphene—Somnolence—Mitoxantrone—prostate cancer	0.000144	0.000889	CcSEcCtD
Dextropropoxyphene—Dizziness—Conjugated Estrogens—prostate cancer	0.000144	0.000886	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Estradiol—prostate cancer	0.000143	0.000884	CcSEcCtD
Dextropropoxyphene—Convulsion—Etoposide—prostate cancer	0.000143	0.000883	CcSEcCtD
Dextropropoxyphene—Eye disorder—Capecitabine—prostate cancer	0.000143	0.00088	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Mitoxantrone—prostate cancer	0.000143	0.00088	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Docetaxel—prostate cancer	0.000142	0.000878	CcSEcCtD
Dextropropoxyphene—Toremifene—CYP1A1—prostate cancer	0.000142	0.0287	CrCbGaD
Dextropropoxyphene—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.000142	0.000877	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Estradiol—prostate cancer	0.000142	0.000877	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Docetaxel—prostate cancer	0.000142	0.000876	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Epirubicin—prostate cancer	0.000142	0.000875	CcSEcCtD
Dextropropoxyphene—Levomethadyl Acetate—CYP3A5—prostate cancer	0.000142	0.0286	CrCbGaD
Dextropropoxyphene—Cardiac disorder—Capecitabine—prostate cancer	0.000142	0.000874	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Docetaxel—prostate cancer	0.000141	0.000869	CcSEcCtD
Dextropropoxyphene—Vomiting—Goserelin—prostate cancer	0.00014	0.00086	CcSEcCtD
Dextropropoxyphene—Discomfort—Etoposide—prostate cancer	0.000139	0.000857	CcSEcCtD
Dextropropoxyphene—Constipation—Mitoxantrone—prostate cancer	0.000139	0.000855	CcSEcCtD
Dextropropoxyphene—Bradycardia—Prednisone—prostate cancer	0.000138	0.000854	CcSEcCtD
Dextropropoxyphene—Rash—Goserelin—prostate cancer	0.000138	0.000853	CcSEcCtD
Dextropropoxyphene—Dermatitis—Goserelin—prostate cancer	0.000138	0.000852	CcSEcCtD
Dextropropoxyphene—Vomiting—Conjugated Estrogens—prostate cancer	0.000138	0.000852	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Capecitabine—prostate cancer	0.000138	0.00085	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Capecitabine—prostate cancer	0.000138	0.000849	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Estradiol—prostate cancer	0.000138	0.000848	CcSEcCtD
Dextropropoxyphene—Headache—Goserelin—prostate cancer	0.000137	0.000848	CcSEcCtD
Dextropropoxyphene—Malnutrition—Docetaxel—prostate cancer	0.000137	0.000847	CcSEcCtD
Dextropropoxyphene—Rash—Conjugated Estrogens—prostate cancer	0.000137	0.000845	CcSEcCtD
Dextropropoxyphene—Dermatitis—Conjugated Estrogens—prostate cancer	0.000137	0.000844	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Capecitabine—prostate cancer	0.000136	0.000841	CcSEcCtD
Dextropropoxyphene—Headache—Conjugated Estrogens—prostate cancer	0.000136	0.00084	CcSEcCtD
Dextropropoxyphene—Confusional state—Etoposide—prostate cancer	0.000136	0.000838	CcSEcCtD
Dextropropoxyphene—Hallucination—Prednisone—prostate cancer	0.000135	0.000834	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—prostate cancer	0.000135	0.000834	CcSEcCtD
Dextropropoxyphene—Ataxia—Doxorubicin—prostate cancer	0.000134	0.000825	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Mitoxantrone—prostate cancer	0.000134	0.000824	CcSEcCtD
Dextropropoxyphene—Malnutrition—Capecitabine—prostate cancer	0.000133	0.00082	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000133	0.000817	CcSEcCtD
Dextropropoxyphene—Tachycardia—Etoposide—prostate cancer	0.000132	0.000811	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—prostate cancer	0.000131	0.00081	CcSEcCtD
Dextropropoxyphene—Diphenhydramine—CYP2C18—prostate cancer	0.000131	0.0263	CrCbGaD
Dextropropoxyphene—Levomethadyl Acetate—CYP19A1—prostate cancer	0.000131	0.0263	CrCbGaD
Dextropropoxyphene—Nausea—Goserelin—prostate cancer	0.00013	0.000804	CcSEcCtD
Dextropropoxyphene—Nausea—Conjugated Estrogens—prostate cancer	0.000129	0.000796	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Estradiol—prostate cancer	0.000128	0.00079	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Mitoxantrone—prostate cancer	0.000128	0.00079	CcSEcCtD
Dextropropoxyphene—Phenoxybenzamine—SLC22A1—prostate cancer	0.000127	0.0256	CrCbGaD
Dextropropoxyphene—Eye disorder—Prednisone—prostate cancer	0.000127	0.000784	CcSEcCtD
Dextropropoxyphene—Methadone—CYP2C18—prostate cancer	0.000126	0.0254	CrCbGaD
Dextropropoxyphene—Hypotension—Etoposide—prostate cancer	0.000126	0.000777	CcSEcCtD
Dextropropoxyphene—Vision blurred—Capecitabine—prostate cancer	0.000125	0.000772	CcSEcCtD
Dextropropoxyphene—Asthenia—Estradiol—prostate cancer	0.000125	0.00077	CcSEcCtD
Dextropropoxyphene—Modafinil—CYP3A5—prostate cancer	0.000124	0.025	CrCbGaD
Dextropropoxyphene—Syncope—Docetaxel—prostate cancer	0.000123	0.000759	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Prednisone—prostate cancer	0.000123	0.000758	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Prednisone—prostate cancer	0.000121	0.000749	CcSEcCtD
Dextropropoxyphene—Fentanyl—CYP3A5—prostate cancer	0.000121	0.0244	CrCbGaD
Dextropropoxyphene—Loss of consciousness—Docetaxel—prostate cancer	0.000121	0.000744	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Etoposide—prostate cancer	0.00012	0.000741	CcSEcCtD
Dextropropoxyphene—Somnolence—Etoposide—prostate cancer	0.00012	0.000739	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Mitoxantrone—prostate cancer	0.000119	0.000736	CcSEcCtD
Dextropropoxyphene—Syncope—Capecitabine—prostate cancer	0.000119	0.000735	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Estradiol—prostate cancer	0.000119	0.000734	CcSEcCtD
Dextropropoxyphene—Convulsion—Docetaxel—prostate cancer	0.000119	0.000733	CcSEcCtD
Dextropropoxyphene—Drowsiness—Epirubicin—prostate cancer	0.000118	0.000731	CcSEcCtD
Dextropropoxyphene—Malnutrition—Prednisone—prostate cancer	0.000118	0.00073	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Capecitabine—prostate cancer	0.000117	0.00072	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Etoposide—prostate cancer	0.000116	0.000718	CcSEcCtD
Dextropropoxyphene—Asthenia—Mitoxantrone—prostate cancer	0.000116	0.000717	CcSEcCtD
Dextropropoxyphene—Jaundice—Epirubicin—prostate cancer	0.000115	0.000712	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ESR2—prostate cancer	0.000115	0.0232	CrCbGaD
Dextropropoxyphene—Constipation—Etoposide—prostate cancer	0.000115	0.000711	CcSEcCtD
Dextropropoxyphene—Dizziness—Estradiol—prostate cancer	0.000115	0.000709	CcSEcCtD
Dextropropoxyphene—Confusional state—Docetaxel—prostate cancer	0.000113	0.000697	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—prostate cancer	0.000112	0.000691	CcSEcCtD
Dextropropoxyphene—Discomfort—Capecitabine—prostate cancer	0.000112	0.000689	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisone—prostate cancer	0.000112	0.000688	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Etoposide—prostate cancer	0.000111	0.000685	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Mitoxantrone—prostate cancer	0.000111	0.000684	CcSEcCtD
Dextropropoxyphene—Vomiting—Estradiol—prostate cancer	0.000111	0.000682	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Etoposide—prostate cancer	0.00011	0.00068	CcSEcCtD
Dextropropoxyphene—Shock—Docetaxel—prostate cancer	0.00011	0.00068	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Docetaxel—prostate cancer	0.00011	0.000678	CcSEcCtD
Dextropropoxyphene—Rash—Estradiol—prostate cancer	0.00011	0.000676	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—prostate cancer	0.00011	0.000676	CcSEcCtD
Dextropropoxyphene—Dermatitis—Estradiol—prostate cancer	0.00011	0.000676	CcSEcCtD
Dextropropoxyphene—Confusional state—Capecitabine—prostate cancer	0.000109	0.000674	CcSEcCtD
Dextropropoxyphene—Tachycardia—Docetaxel—prostate cancer	0.000109	0.000674	CcSEcCtD
Dextropropoxyphene—Headache—Estradiol—prostate cancer	0.000109	0.000672	CcSEcCtD
Dextropropoxyphene—Agitation—Prednisone—prostate cancer	0.000109	0.000671	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—prostate cancer	0.000108	0.000668	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—prostate cancer	0.000107	0.000659	CcSEcCtD
Dextropropoxyphene—Diphenhydramine—SLC22A1—prostate cancer	0.000107	0.0215	CrCbGaD
Dextropropoxyphene—Shock—Capecitabine—prostate cancer	0.000107	0.000658	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Etoposide—prostate cancer	0.000107	0.000657	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Capecitabine—prostate cancer	0.000106	0.000656	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisone—prostate cancer	0.000106	0.000655	CcSEcCtD
Dextropropoxyphene—Tachycardia—Capecitabine—prostate cancer	0.000106	0.000653	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP1B1—prostate cancer	0.000105	0.0212	CrCbGaD
Dextropropoxyphene—Hypotension—Docetaxel—prostate cancer	0.000105	0.000646	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisone—prostate cancer	0.000104	0.000642	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000104	0.000639	CcSEcCtD
Dextropropoxyphene—Nausea—Estradiol—prostate cancer	0.000103	0.000637	CcSEcCtD
Dextropropoxyphene—Vomiting—Mitoxantrone—prostate cancer	0.000103	0.000635	CcSEcCtD
Dextropropoxyphene—Convulsion—Prednisone—prostate cancer	0.000103	0.000633	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—prostate cancer	0.000103	0.000632	CcSEcCtD
Dextropropoxyphene—Rash—Mitoxantrone—prostate cancer	0.000102	0.00063	CcSEcCtD
Dextropropoxyphene—Dermatitis—Mitoxantrone—prostate cancer	0.000102	0.00063	CcSEcCtD
Dextropropoxyphene—Headache—Mitoxantrone—prostate cancer	0.000102	0.000626	CcSEcCtD
Dextropropoxyphene—Hypotension—Capecitabine—prostate cancer	0.000101	0.000625	CcSEcCtD
Dextropropoxyphene—Insomnia—Docetaxel—prostate cancer	0.000101	0.000625	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—prostate cancer	0.0001	0.000618	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Docetaxel—prostate cancer	9.99e-05	0.000616	CcSEcCtD
Dextropropoxyphene—Somnolence—Docetaxel—prostate cancer	9.96e-05	0.000614	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisone—prostate cancer	9.96e-05	0.000614	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—prostate cancer	9.94e-05	0.000613	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Etoposide—prostate cancer	9.93e-05	0.000613	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—prostate cancer	9.87e-05	0.000609	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Docetaxel—prostate cancer	9.86e-05	0.000608	CcSEcCtD
Dextropropoxyphene—Insomnia—Capecitabine—prostate cancer	9.81e-05	0.000605	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Docetaxel—prostate cancer	9.67e-05	0.000596	CcSEcCtD
Dextropropoxyphene—Asthenia—Etoposide—prostate cancer	9.67e-05	0.000596	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Capecitabine—prostate cancer	9.67e-05	0.000596	CcSEcCtD
Dextropropoxyphene—Nausea—Mitoxantrone—prostate cancer	9.63e-05	0.000594	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—prostate cancer	9.61e-05	0.000592	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—prostate cancer	9.59e-05	0.000591	CcSEcCtD
Dextropropoxyphene—Constipation—Docetaxel—prostate cancer	9.58e-05	0.000591	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Capecitabine—prostate cancer	9.55e-05	0.000589	CcSEcCtD
Dextropropoxyphene—Shock—Prednisone—prostate cancer	9.51e-05	0.000586	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—prostate cancer	9.5e-05	0.000586	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—prostate cancer	9.48e-05	0.000585	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Prednisone—prostate cancer	9.48e-05	0.000584	CcSEcCtD
Dextropropoxyphene—Tachycardia—Prednisone—prostate cancer	9.43e-05	0.000582	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Capecitabine—prostate cancer	9.36e-05	0.000578	CcSEcCtD
Dextropropoxyphene—Constipation—Capecitabine—prostate cancer	9.28e-05	0.000572	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—prostate cancer	9.26e-05	0.000571	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Docetaxel—prostate cancer	9.23e-05	0.000569	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Etoposide—prostate cancer	9.22e-05	0.000569	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—prostate cancer	9.2e-05	0.000567	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Docetaxel—prostate cancer	9.16e-05	0.000565	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—prostate cancer	9.13e-05	0.000563	CcSEcCtD
Dextropropoxyphene—Toremifene—CYP3A4—prostate cancer	9.09e-05	0.0183	CrCbGaD
Dextropropoxyphene—Feeling abnormal—Capecitabine—prostate cancer	8.94e-05	0.000551	CcSEcCtD
Dextropropoxyphene—Dizziness—Etoposide—prostate cancer	8.91e-05	0.00055	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—prostate cancer	8.89e-05	0.000548	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Capecitabine—prostate cancer	8.87e-05	0.000547	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—prostate cancer	8.87e-05	0.000547	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Docetaxel—prostate cancer	8.86e-05	0.000546	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—prostate cancer	8.79e-05	0.000542	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisone—prostate cancer	8.74e-05	0.000539	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—prostate cancer	8.73e-05	0.000538	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Capecitabine—prostate cancer	8.58e-05	0.000529	CcSEcCtD
Dextropropoxyphene—Vomiting—Etoposide—prostate cancer	8.57e-05	0.000529	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—prostate cancer	8.57e-05	0.000528	CcSEcCtD
Dextropropoxyphene—Alimemazine—CYP3A4—prostate cancer	8.53e-05	0.0172	CrCbGaD
Dextropropoxyphene—Agitation—Epirubicin—prostate cancer	8.51e-05	0.000525	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Prednisone—prostate cancer	8.51e-05	0.000525	CcSEcCtD
Dextropropoxyphene—Rash—Etoposide—prostate cancer	8.5e-05	0.000524	CcSEcCtD
Dextropropoxyphene—Dermatitis—Etoposide—prostate cancer	8.49e-05	0.000524	CcSEcCtD
Dextropropoxyphene—Headache—Etoposide—prostate cancer	8.45e-05	0.000521	CcSEcCtD
Dextropropoxyphene—Modafinil—CYP2C19—prostate cancer	8.44e-05	0.017	CrCbGaD
Dextropropoxyphene—Tamoxifen—CYP3A5—prostate cancer	8.39e-05	0.0169	CrCbGaD
Dextropropoxyphene—Methadone—CYP3A5—prostate cancer	8.32e-05	0.0167	CrCbGaD
Dextropropoxyphene—Syncope—Epirubicin—prostate cancer	8.3e-05	0.000512	CcSEcCtD
Dextropropoxyphene—Constipation—Prednisone—prostate cancer	8.26e-05	0.00051	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Docetaxel—prostate cancer	8.25e-05	0.000509	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Epirubicin—prostate cancer	8.14e-05	0.000502	CcSEcCtD
Dextropropoxyphene—Phenoxybenzamine—ADRB2—prostate cancer	8.12e-05	0.0164	CrCbGaD
Dextropropoxyphene—Tamoxifen—CYP2A6—prostate cancer	8.12e-05	0.0163	CrCbGaD
Dextropropoxyphene—Vision blurred—Doxorubicin—prostate cancer	8.07e-05	0.000498	CcSEcCtD
Dextropropoxyphene—Asthenia—Docetaxel—prostate cancer	8.04e-05	0.000496	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—prostate cancer	8.02e-05	0.000495	CcSEcCtD
Dextropropoxyphene—Nausea—Etoposide—prostate cancer	8.01e-05	0.000494	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Capecitabine—prostate cancer	7.99e-05	0.000493	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisone—prostate cancer	7.96e-05	0.000491	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Prednisone—prostate cancer	7.9e-05	0.000487	CcSEcCtD
Dextropropoxyphene—Agitation—Doxorubicin—prostate cancer	7.87e-05	0.000486	CcSEcCtD
Dextropropoxyphene—Discomfort—Epirubicin—prostate cancer	7.79e-05	0.00048	CcSEcCtD
Dextropropoxyphene—Asthenia—Capecitabine—prostate cancer	7.78e-05	0.00048	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP19A1—prostate cancer	7.73e-05	0.0156	CrCbGaD
Dextropropoxyphene—Syncope—Doxorubicin—prostate cancer	7.68e-05	0.000474	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Docetaxel—prostate cancer	7.67e-05	0.000473	CcSEcCtD
Dextropropoxyphene—Methadone—CYP19A1—prostate cancer	7.66e-05	0.0154	CrCbGaD
Dextropropoxyphene—Abdominal pain—Prednisone—prostate cancer	7.64e-05	0.000471	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—prostate cancer	7.62e-05	0.00047	CcSEcCtD
Dextropropoxyphene—Disopyramide—CYP3A4—prostate cancer	7.53e-05	0.0152	CrCbGaD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—prostate cancer	7.53e-05	0.000464	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—prostate cancer	7.43e-05	0.000458	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—prostate cancer	7.42e-05	0.000458	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Capecitabine—prostate cancer	7.42e-05	0.000458	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—prostate cancer	7.41e-05	0.000457	CcSEcCtD
Dextropropoxyphene—Dizziness—Docetaxel—prostate cancer	7.41e-05	0.000457	CcSEcCtD
Dextropropoxyphene—Tachycardia—Epirubicin—prostate cancer	7.38e-05	0.000455	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—prostate cancer	7.21e-05	0.000444	CcSEcCtD
Dextropropoxyphene—Dizziness—Capecitabine—prostate cancer	7.17e-05	0.000442	CcSEcCtD
Dextropropoxyphene—Vomiting—Docetaxel—prostate cancer	7.12e-05	0.000439	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Prednisone—prostate cancer	7.12e-05	0.000439	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ESR1—prostate cancer	7.11e-05	0.0143	CrCbGaD
Dextropropoxyphene—Rash—Docetaxel—prostate cancer	7.06e-05	0.000436	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—prostate cancer	7.06e-05	0.000435	CcSEcCtD
Dextropropoxyphene—Dermatitis—Docetaxel—prostate cancer	7.06e-05	0.000435	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—prostate cancer	7.05e-05	0.000435	CcSEcCtD
Dextropropoxyphene—Headache—Docetaxel—prostate cancer	7.02e-05	0.000433	CcSEcCtD
Dextropropoxyphene—Asthenia—Prednisone—prostate cancer	6.93e-05	0.000428	CcSEcCtD
Dextropropoxyphene—Vomiting—Capecitabine—prostate cancer	6.9e-05	0.000425	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—prostate cancer	6.88e-05	0.000424	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—prostate cancer	6.86e-05	0.000423	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—CYP3A4—prostate cancer	6.85e-05	0.0138	CrCbGaD
Dextropropoxyphene—Rash—Capecitabine—prostate cancer	6.84e-05	0.000422	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—prostate cancer	6.83e-05	0.000421	CcSEcCtD
Dextropropoxyphene—Dermatitis—Capecitabine—prostate cancer	6.83e-05	0.000421	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—prostate cancer	6.82e-05	0.000421	CcSEcCtD
Dextropropoxyphene—Headache—Capecitabine—prostate cancer	6.8e-05	0.000419	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Epirubicin—prostate cancer	6.74e-05	0.000415	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—prostate cancer	6.72e-05	0.000414	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—PTGS2—prostate cancer	6.71e-05	0.0135	CrCbGaD
Dextropropoxyphene—Nausea—Docetaxel—prostate cancer	6.65e-05	0.00041	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Epirubicin—prostate cancer	6.65e-05	0.00041	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Prednisone—prostate cancer	6.61e-05	0.000408	CcSEcCtD
Dextropropoxyphene—Hypotension—Doxorubicin—prostate cancer	6.53e-05	0.000403	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—prostate cancer	6.52e-05	0.000402	CcSEcCtD
Dextropropoxyphene—Constipation—Epirubicin—prostate cancer	6.46e-05	0.000399	CcSEcCtD
Dextropropoxyphene—Nausea—Capecitabine—prostate cancer	6.44e-05	0.000397	CcSEcCtD
Dextropropoxyphene—Propafenone—CYP3A4—prostate cancer	6.4e-05	0.0129	CrCbGaD
Dextropropoxyphene—Dizziness—Prednisone—prostate cancer	6.39e-05	0.000394	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—prostate cancer	6.32e-05	0.00039	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Doxorubicin—prostate cancer	6.23e-05	0.000384	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—prostate cancer	6.23e-05	0.000384	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—prostate cancer	6.22e-05	0.000383	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—prostate cancer	6.18e-05	0.000381	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—prostate cancer	6.15e-05	0.00038	CcSEcCtD
Dextropropoxyphene—Vomiting—Prednisone—prostate cancer	6.14e-05	0.000379	CcSEcCtD
Dextropropoxyphene—Levomethadyl Acetate—CYP3A4—prostate cancer	6.14e-05	0.0124	CrCbGaD
Dextropropoxyphene—Rash—Prednisone—prostate cancer	6.09e-05	0.000376	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisone—prostate cancer	6.09e-05	0.000375	CcSEcCtD
Dextropropoxyphene—Headache—Prednisone—prostate cancer	6.05e-05	0.000373	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.04e-05	0.000372	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—prostate cancer	5.98e-05	0.000369	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—prostate cancer	5.97e-05	0.000368	CcSEcCtD
Dextropropoxyphene—Trimipramine—CYP2C19—prostate cancer	5.97e-05	0.012	CrCbGaD
Dextropropoxyphene—Diphenhydramine—CYP2C19—prostate cancer	5.86e-05	0.0118	CrCbGaD
Dextropropoxyphene—Tamoxifen—CYP2E1—prostate cancer	5.76e-05	0.0116	CrCbGaD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—prostate cancer	5.76e-05	0.000355	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisone—prostate cancer	5.74e-05	0.000354	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—prostate cancer	5.72e-05	0.000353	CcSEcCtD
Dextropropoxyphene—Tamoxifen—CYP2C19—prostate cancer	5.71e-05	0.0115	CrCbGaD
Dextropropoxyphene—Tamoxifen—CYP1A1—prostate cancer	5.69e-05	0.0114	CrCbGaD
Dextropropoxyphene—Methadone—CYP2C19—prostate cancer	5.66e-05	0.0114	CrCbGaD
Dextropropoxyphene—Orphenadrine—CYP2E1—prostate cancer	5.6e-05	0.0113	CrCbGaD
Dextropropoxyphene—Hypersensitivity—Epirubicin—prostate cancer	5.57e-05	0.000343	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—prostate cancer	5.53e-05	0.000341	CcSEcCtD
Dextropropoxyphene—Asthenia—Epirubicin—prostate cancer	5.42e-05	0.000334	CcSEcCtD
Dextropropoxyphene—Modafinil—CYP3A4—prostate cancer	5.37e-05	0.0108	CrCbGaD
Dextropropoxyphene—Fentanyl—CYP3A4—prostate cancer	5.25e-05	0.0106	CrCbGaD
Dextropropoxyphene—Diarrhoea—Epirubicin—prostate cancer	5.17e-05	0.000319	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—prostate cancer	5.15e-05	0.000318	CcSEcCtD
Dextropropoxyphene—Loperamide—CYP3A4—prostate cancer	5.06e-05	0.0102	CrCbGaD
Dextropropoxyphene—Asthenia—Doxorubicin—prostate cancer	5.02e-05	0.000309	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—prostate cancer	5e-05	0.000308	CcSEcCtD
Dextropropoxyphene—Vomiting—Epirubicin—prostate cancer	4.8e-05	0.000296	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—prostate cancer	4.78e-05	0.000295	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—prostate cancer	4.76e-05	0.000294	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—prostate cancer	4.76e-05	0.000294	CcSEcCtD
Dextropropoxyphene—Headache—Epirubicin—prostate cancer	4.73e-05	0.000292	CcSEcCtD
Dextropropoxyphene—Benzphetamine—CYP3A4—prostate cancer	4.65e-05	0.00937	CrCbGaD
Dextropropoxyphene—Dizziness—Doxorubicin—prostate cancer	4.62e-05	0.000285	CcSEcCtD
Dextropropoxyphene—Nausea—Epirubicin—prostate cancer	4.49e-05	0.000277	CcSEcCtD
Dextropropoxyphene—Phenoxybenzamine—CYP3A4—prostate cancer	4.45e-05	0.00895	CrCbGaD
Dextropropoxyphene—Vomiting—Doxorubicin—prostate cancer	4.45e-05	0.000274	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—prostate cancer	4.41e-05	0.000272	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—prostate cancer	4.4e-05	0.000272	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—prostate cancer	4.38e-05	0.00027	CcSEcCtD
Dextropropoxyphene—Nausea—Doxorubicin—prostate cancer	4.15e-05	0.000256	CcSEcCtD
Dextropropoxyphene—Trimipramine—CYP3A4—prostate cancer	3.8e-05	0.00764	CrCbGaD
Dextropropoxyphene—Tamoxifen—CYP3A4—prostate cancer	3.63e-05	0.00731	CrCbGaD
Dextropropoxyphene—Methadone—CYP3A4—prostate cancer	3.6e-05	0.00725	CrCbGaD
Dextropropoxyphene—Orphenadrine—CYP3A4—prostate cancer	3.53e-05	0.0071	CrCbGaD
Dextropropoxyphene—CYP3A7—Metabolism—INS—prostate cancer	5.05e-06	4.43e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CDKN1B—prostate cancer	5.03e-06	4.41e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC5A5—prostate cancer	4.98e-06	4.37e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—AKT1—prostate cancer	4.97e-06	4.36e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GSK3B—prostate cancer	4.97e-06	4.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.96e-06	4.35e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—JAK2—prostate cancer	4.95e-06	4.34e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CREBBP—prostate cancer	4.94e-06	4.33e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC5A5—prostate cancer	4.94e-06	4.33e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTA1—prostate cancer	4.94e-06	4.33e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CASP3—prostate cancer	4.93e-06	4.32e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL2—prostate cancer	4.92e-06	4.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—COMT—prostate cancer	4.91e-06	4.31e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—INS—prostate cancer	4.91e-06	4.3e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL6—prostate cancer	4.9e-06	4.29e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTP1—prostate cancer	4.89e-06	4.29e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.88e-06	4.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTO1—prostate cancer	4.88e-06	4.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NAT2—prostate cancer	4.88e-06	4.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.87e-06	4.27e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PIK3CA—prostate cancer	4.85e-06	4.25e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MDM2—prostate cancer	4.83e-06	4.24e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP2E1—prostate cancer	4.83e-06	4.23e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NQO1—prostate cancer	4.81e-06	4.22e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ITPR1—prostate cancer	4.81e-06	4.22e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CREBBP—prostate cancer	4.8e-06	4.21e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCND1—prostate cancer	4.8e-06	4.21e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NQO1—prostate cancer	4.77e-06	4.19e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ERBB2—prostate cancer	4.76e-06	4.18e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CTNNB1—prostate cancer	4.75e-06	4.17e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF1—prostate cancer	4.74e-06	4.16e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TH—prostate cancer	4.74e-06	4.16e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.73e-06	4.15e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—EGFR—prostate cancer	4.72e-06	4.14e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TH—prostate cancer	4.7e-06	4.13e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CB—prostate cancer	4.7e-06	4.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.69e-06	4.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CD—prostate cancer	4.69e-06	4.11e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.68e-06	4.11e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PLCB2—prostate cancer	4.68e-06	4.11e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LRP2—prostate cancer	4.68e-06	4.11e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.67e-06	4.1e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MMP9—prostate cancer	4.66e-06	4.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP3A4—prostate cancer	4.65e-06	4.08e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CDKN1A—prostate cancer	4.64e-06	4.07e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.63e-06	4.06e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PTEN—prostate cancer	4.63e-06	4.06e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.62e-06	4.05e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—P4HB—prostate cancer	4.59e-06	4.03e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAP2K1—prostate cancer	4.59e-06	4.02e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP1B1—prostate cancer	4.58e-06	4.01e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CD—prostate cancer	4.56e-06	4e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—TYMS—prostate cancer	4.55e-06	3.99e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—AKT1—prostate cancer	4.52e-06	3.96e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCL8—prostate cancer	4.51e-06	3.96e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—PIK3CA—prostate cancer	4.51e-06	3.96e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SERPINE1—prostate cancer	4.51e-06	3.95e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTM1—prostate cancer	4.49e-06	3.94e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GGT1—prostate cancer	4.47e-06	3.92e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.47e-06	3.92e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—KRAS—prostate cancer	4.46e-06	3.91e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GGT1—prostate cancer	4.43e-06	3.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—NOS3—prostate cancer	4.42e-06	3.88e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EP300—prostate cancer	4.42e-06	3.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—LPL—prostate cancer	4.41e-06	3.87e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	4.41e-06	3.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NCOA1—prostate cancer	4.4e-06	3.86e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NCOA1—prostate cancer	4.36e-06	3.83e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—FGF2—prostate cancer	4.36e-06	3.83e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	4.36e-06	3.83e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.35e-06	3.82e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.34e-06	3.81e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CASP3—prostate cancer	4.32e-06	3.79e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL2—prostate cancer	4.31e-06	3.78e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP19A1—prostate cancer	4.3e-06	3.77e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NOS3—prostate cancer	4.3e-06	3.77e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SRC—prostate cancer	4.29e-06	3.77e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL6—prostate cancer	4.29e-06	3.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MED12—prostate cancer	4.28e-06	3.76e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP1A1—prostate cancer	4.26e-06	3.74e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GNG5—prostate cancer	4.25e-06	3.73e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ERCC2—prostate cancer	4.23e-06	3.71e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCND1—prostate cancer	4.21e-06	3.69e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—RXRA—prostate cancer	4.19e-06	3.67e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VEGFA—prostate cancer	4.18e-06	3.67e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JAK2—prostate cancer	4.18e-06	3.67e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	4.17e-06	3.65e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—RXRA—prostate cancer	4.15e-06	3.64e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—STAT3—prostate cancer	4.14e-06	3.63e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	4.1e-06	3.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOA3—prostate cancer	4.09e-06	3.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CB—prostate cancer	4.08e-06	3.58e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MMP9—prostate cancer	4.08e-06	3.58e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MDM2—prostate cancer	4.08e-06	3.58e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	4.07e-06	3.57e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PTEN—prostate cancer	4.06e-06	3.56e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS2—prostate cancer	4.05e-06	3.55e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.04e-06	3.54e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—COMT—prostate cancer	4.03e-06	3.54e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ERBB2—prostate cancer	4.02e-06	3.53e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTP1—prostate cancer	4.01e-06	3.52e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—COMT—prostate cancer	4e-06	3.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTP1—prostate cancer	3.98e-06	3.49e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—MTHFR—prostate cancer	3.97e-06	3.48e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	3.97e-06	3.48e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—AKT1—prostate cancer	3.96e-06	3.47e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ITPR1—prostate cancer	3.95e-06	3.47e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ITPR1—prostate cancer	3.92e-06	3.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HPGDS—prostate cancer	3.9e-06	3.42e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PPARA—prostate cancer	3.9e-06	3.42e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.88e-06	3.4e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EP300—prostate cancer	3.87e-06	3.4e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.85e-06	3.38e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MYC—prostate cancer	3.85e-06	3.37e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TGFB1—prostate cancer	3.84e-06	3.37e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCL8—prostate cancer	3.82e-06	3.35e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTT1—prostate cancer	3.79e-06	3.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ACHE—prostate cancer	3.79e-06	3.32e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SRC—prostate cancer	3.76e-06	3.3e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EGFR—prostate cancer	3.76e-06	3.3e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.74e-06	3.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TYMS—prostate cancer	3.73e-06	3.27e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	3.73e-06	3.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TYMS—prostate cancer	3.7e-06	3.25e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTM1—prostate cancer	3.69e-06	3.24e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	3.69e-06	3.23e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VEGFA—prostate cancer	3.67e-06	3.22e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CAV1—prostate cancer	3.66e-06	3.21e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTM1—prostate cancer	3.66e-06	3.21e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CASP3—prostate cancer	3.65e-06	3.2e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL2—prostate cancer	3.65e-06	3.2e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.64e-06	3.19e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—STAT3—prostate cancer	3.63e-06	3.18e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL6—prostate cancer	3.63e-06	3.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PRKACB—prostate cancer	3.62e-06	3.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—LPL—prostate cancer	3.62e-06	3.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—LPL—prostate cancer	3.59e-06	3.15e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.58e-06	3.14e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KRAS—prostate cancer	3.56e-06	3.12e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCND1—prostate cancer	3.55e-06	3.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTEN—prostate cancer	3.53e-06	3.1e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	3.52e-06	3.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.5e-06	3.07e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.5e-06	3.07e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ERCC2—prostate cancer	3.47e-06	3.04e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.47e-06	3.04e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MMP9—prostate cancer	3.45e-06	3.03e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ERCC2—prostate cancer	3.44e-06	3.02e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	3.44e-06	3.02e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PTEN—prostate cancer	3.43e-06	3.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOA2—prostate cancer	3.42e-06	3e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MYC—prostate cancer	3.37e-06	2.96e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—EP300—prostate cancer	3.37e-06	2.95e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TGFB1—prostate cancer	3.37e-06	2.95e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—AKT1—prostate cancer	3.35e-06	2.94e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CG—prostate cancer	3.34e-06	2.93e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EGFR—prostate cancer	3.3e-06	2.89e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EP300—prostate cancer	3.27e-06	2.87e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	3.27e-06	2.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—MTHFR—prostate cancer	3.26e-06	2.86e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.26e-06	2.86e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—MTHFR—prostate cancer	3.23e-06	2.84e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PPARA—prostate cancer	3.2e-06	2.81e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.18e-06	2.79e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SRC—prostate cancer	3.18e-06	2.79e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PPARA—prostate cancer	3.17e-06	2.78e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TP53—prostate cancer	3.16e-06	2.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—INS—prostate cancer	3.16e-06	2.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NQO1—prostate cancer	3.15e-06	2.76e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KRAS—prostate cancer	3.12e-06	2.73e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TH—prostate cancer	3.1e-06	2.72e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VEGFA—prostate cancer	3.1e-06	2.72e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CREBBP—prostate cancer	3.09e-06	2.71e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—STAT3—prostate cancer	3.07e-06	2.69e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.02e-06	2.65e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CAV1—prostate cancer	3.01e-06	2.64e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CAV1—prostate cancer	2.98e-06	2.62e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CD—prostate cancer	2.93e-06	2.57e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GGT1—prostate cancer	2.92e-06	2.56e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL6—prostate cancer	2.89e-06	2.54e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOA1—prostate cancer	2.88e-06	2.52e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	2.86e-06	2.51e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MYC—prostate cancer	2.85e-06	2.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.85e-06	2.5e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TGFB1—prostate cancer	2.84e-06	2.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.84e-06	2.49e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EGFR—prostate cancer	2.79e-06	2.45e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TP53—prostate cancer	2.77e-06	2.43e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NOS3—prostate cancer	2.77e-06	2.43e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.74e-06	2.4e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—RXRA—prostate cancer	2.74e-06	2.4e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.72e-06	2.38e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—AKT1—prostate cancer	2.67e-06	2.34e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—COMT—prostate cancer	2.64e-06	2.31e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KRAS—prostate cancer	2.63e-06	2.31e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTP1—prostate cancer	2.62e-06	2.3e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—INS—prostate cancer	2.59e-06	2.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ITPR1—prostate cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—INS—prostate cancer	2.57e-06	2.26e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CB—prostate cancer	2.56e-06	2.24e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CREBBP—prostate cancer	2.54e-06	2.23e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL6—prostate cancer	2.54e-06	2.22e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS2—prostate cancer	2.53e-06	2.22e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CREBBP—prostate cancer	2.52e-06	2.21e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CA—prostate cancer	2.49e-06	2.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TYMS—prostate cancer	2.44e-06	2.14e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	2.42e-06	2.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTM1—prostate cancer	2.41e-06	2.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.41e-06	2.11e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.39e-06	2.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LPL—prostate cancer	2.37e-06	2.08e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TP53—prostate cancer	2.34e-06	2.05e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AKT1—prostate cancer	2.34e-06	2.05e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.29e-06	2.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NOS3—prostate cancer	2.27e-06	1.99e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ERCC2—prostate cancer	2.27e-06	1.99e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NOS3—prostate cancer	2.25e-06	1.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTEN—prostate cancer	2.21e-06	1.94e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL6—prostate cancer	2.14e-06	1.88e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MTHFR—prostate cancer	2.13e-06	1.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—EP300—prostate cancer	2.11e-06	1.85e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.1e-06	1.84e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPARA—prostate cancer	2.09e-06	1.83e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.08e-06	1.83e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS2—prostate cancer	2.08e-06	1.82e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS2—prostate cancer	2.06e-06	1.81e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—AKT1—prostate cancer	2.03e-06	1.78e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AKT1—prostate cancer	1.98e-06	1.73e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CAV1—prostate cancer	1.97e-06	1.72e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTEN—prostate cancer	1.81e-06	1.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTEN—prostate cancer	1.8e-06	1.58e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.79e-06	1.57e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—EP300—prostate cancer	1.73e-06	1.52e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—EP300—prostate cancer	1.71e-06	1.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—INS—prostate cancer	1.7e-06	1.49e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CREBBP—prostate cancer	1.66e-06	1.46e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.57e-06	1.38e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.56e-06	1.37e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NOS3—prostate cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.37e-06	1.2e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS2—prostate cancer	1.36e-06	1.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.28e-06	1.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AKT1—prostate cancer	1.27e-06	1.12e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.27e-06	1.11e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTEN—prostate cancer	1.19e-06	1.04e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—EP300—prostate cancer	1.13e-06	9.92e-06	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AKT1—prostate cancer	1.05e-06	9.17e-06	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AKT1—prostate cancer	1.04e-06	9.09e-06	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CA—prostate cancer	8.37e-07	7.34e-06	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AKT1—prostate cancer	6.83e-07	6e-06	CbGpPWpGaD
